Replication fork stalling in WRN-deficient cells is overcome by prompt activation of a MUS81-dependent pathway

Journal of Cell Biology - Tập 183 Số 2 - Trang 241-252 - 2008
Annapaola Franchitto1, Livia Maria Pirzio1, Ennio Prosperi2, O. Sapora1, Margherita Bignami1, Pietro Pichierri1
11Section of Experimental and Computational Carcinogenesis, Istituto Superiore di Sanità, 00161 Rome, Italy
22Istituto di Genetica Molecolare del Consiglio Nazionale delle Ricerche, sez. Istochimica e Citometria, 27100 Pavia, Italy

Tóm tắt

Failure to stabilize and properly process stalled replication forks results in chromosome instability, which is a hallmark of cancer cells and several human genetic conditions that are characterized by cancer predisposition. Loss of WRN, a RecQ-like enzyme mutated in the cancer-prone disease Werner syndrome (WS), leads to rapid accumulation of double-strand breaks (DSBs) and proliferating cell nuclear antigen removal from chromatin upon DNA replication arrest. Knockdown of the MUS81 endonuclease in WRN-deficient cells completely prevents the accumulation of DSBs after fork stalling. Also, MUS81 knockdown in WS cells results in reduced chromatin recruitment of recombination enzymes, decreased yield of sister chromatid exchanges, and reduced survival after replication arrest. Thus, we provide novel evidence that WRN is required to avoid accumulation of DSBs and fork collapse after replication perturbation, and that prompt MUS81-dependent generation of DSBs is instrumental for recovery from hydroxyurea-mediated replication arrest under such pathological conditions.

Từ khóa


Tài liệu tham khảo

2001, J. Mol. Biol., 307, 1235, 10.1006/jmbi.2001.4564

2004, Mol. Biol. Cell., 15, 552, 10.1091/mbc.e03-08-0580

2000, Mol. Cell. Biol., 20, 8758, 10.1128/MCB.20.23.8758-8766.2000

2001, Cell., 107, 537, 10.1016/S0092-8674(01)00536-0

2005, Curr. Opin. Cell Biol., 17, 568, 10.1016/j.ceb.2005.09.003

2002, Cell., 111, 779, 10.1016/S0092-8674(02)01113-3

2002, J. Biomed. Biotechnol., 2, 46, 10.1155/S1110724302201011

2003, J. Biol. Chem., 278, 25172, 10.1074/jbc.M302882200

1998, EMBO J., 17, 159, 10.1093/emboj/17.1.159

2003, EMBO J., 22, 4325, 10.1093/emboj/cdg391

2005, Mol. Cell., 17, 153, 10.1016/j.molcel.2004.11.032

2005, Mol. Cell. Biol., 25, 7569, 10.1128/MCB.25.17.7569-7579.2005

2002, J. Biol. Chem., 277, 32753, 10.1074/jbc.M202120200

2002, Proc. Natl. Acad. Sci. USA., 99, 16887, 10.1073/pnas.252652399

2002, Hum. Mol. Genet., 11, 2447, 10.1093/hmg/11.20.2447

2003, Cancer Res., 63, 3289

2005, DNA Repair (Amst.)., 4, 243, 10.1016/j.dnarep.2004.10.001

2008, Mol. Biol. Cell., 19, 445, 10.1091/mbc.e07-07-0728

2003, Mol. Biol. Cell., 14, 4826, 10.1091/mbc.e03-05-0276

2000, Mutagenesis., 15, 303, 10.1093/mutage/15.4.303

2001, Cell., 107, 551, 10.1016/S0092-8674(01)00593-1

2006, EMBO J., 25, 4921, 10.1038/sj.emboj.7601344

2007, Nat. Struct. Mol. Biol., 14, 1096, 10.1038/nsmb1313

2003, Nat. Rev. Cancer., 3, 169, 10.1038/nrc1012

2000, Mol. Gen. Genet., 263, 812, 10.1007/s004380000241

2003, Cell., 115, 401, 10.1016/S0092-8674(03)00886-9

2005, Genes Dev., 19, 919, 10.1101/gad.1304305

2001, Genes Dev., 15, 2730, 10.1101/gad.932201

2003, Trends Cell Biol., 13, 493, 10.1016/S0962-8924(03)00171-5

2001, Oncogene., 20, 6627, 10.1038/sj.onc.1204813

2003, Genes Dev., 17, 3017, 10.1101/gad.279003

2004, Oncogene., 23, 1206, 10.1038/sj.onc.1207199

2004, Science., 304, 1822, 10.1126/science.1094557

2004, J. Biol. Chem., 279, 20067, 10.1074/jbc.M400022200

2001, Mol. Biol. Cell., 12, 2109, 10.1091/mbc.12.7.2109

2001, Genetics., 157, 103, 10.1093/genetics/157.1.103

1997, Mol. Cell. Biol., 17, 6868, 10.1128/MCB.17.12.6868

2001, Cell., 104, 397, 10.1016/S0092-8674(01)00227-6

2007, DNA Repair (Amst.)., 6, 1004, 10.1016/j.dnarep.2007.02.019

2000, Mutat. Res., 459, 123, 10.1016/S0921-8777(99)00065-8

2001, Mol. Biol. Cell., 12, 2412, 10.1091/mbc.12.8.2412

2004, EMBO J., 23, 3154, 10.1038/sj.emboj.7600277

1993, Cell Motil. Cytoskeleton., 26, 214, 10.1002/cm.970260305

2002, Aging Cell., 1, 30, 10.1046/j.1474-9728.2002.00002.x

2006, Cancer Res., 66, 1675, 10.1158/0008-5472.CAN-05-2741

2001, EMBO J., 20, 3861, 10.1093/emboj/20.14.3861

2002, Mol. Cell. Biol., 22, 6971, 10.1128/MCB.22.20.6971-6978.2002

1982, Hum. Genet., 62, 16, 10.1007/BF00295599

2006, Methods Mol. Biol., 314, 457, 10.1385/1-59259-973-7:457

2007, Mol. Cell. Biol., 27, 5806, 10.1128/MCB.02278-06

2008, J. Mol. Biol., 375, 1152, 10.1016/j.jmb.2007.11.006

1982, Exp. Gerontol., 17, 473, 10.1016/S0531-5565(82)80009-0

2001, Best Pract. Res. Clin. Haematol., 14, 631, 10.1053/beha.2001.0158

2006, EMBO J., 25, 1764, 10.1038/sj.emboj.7601045

2001, J. Biol. Chem., 276, 47759, 10.1074/jbc.C100569200

2003, J. Biol. Chem., 278, 6928, 10.1074/jbc.M210006200

2003, Nature., 426, 870, 10.1038/nature02253

1998, Proc. Natl. Acad. Sci. USA., 95, 8733, 10.1073/pnas.95.15.8733